vTv Therapeutics Target Price

The latest target price for VTVT is $42. Investors often review this figure alongside vTv Therapeutics's historical trend and sector peers before judging valuation or financial health.

vTv Therapeutics trades near $30.46 while the consensus target sits at $42 (37.9% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting VTVT's target price ($42), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack vTv Therapeutics's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.